Pediapharm Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.03 |
Market Cap |
CAD30.42 M |
Shares Outstanding |
77.99 M |
Public Float |
37.88 M |
Address |
1, Place du Commerce Verdun Québec H3E 1A2 Canada |
Employees | - |
Website | http://www.pedia-pharm.com |
Updated | 09/14/2018 |
Pediapharm Inc. operates as a pediatric specialty pharmaceutical company. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children; and commercializes non-prescription products, such as non-prescription drugs, medical devices, and diagnostic products that fulfill unmet medical needs of children. The company portfolio includes NYDA for the treatment of head lice; EpiCeram, a skin barrier repair emulsion for the treatment of dermatitis; KoolEffect Patch, a patch with a hydrogel layer that reduces the skin temperature for an extended period of time when put in direct contact with the skin; Vapolyptus Patch to facilitate children breathe better during bedtime; Tips Haler used to maximize deep deposition of the medication in the lungs. |